In our previous study, He et al. (He et al. 2022) showed that inhibition of cathepsin L following ischemia/reperfusion injury reduces infarct size and improves cardiac contractile function by improving cardiomyocyte function and preventing apoptosis. The gene discussed is CTSL; the disease is ischemia.